Catalyst Pharmaceuticals Acquired by Angelini Pharma | Healthcare M&A Deal

Angelini Pharma has agreed to acquire Catalyst Pharmaceuticals, a pharmacy business in Florida, for $0.001. Catalyst Pharmaceuticals develops and commercializes specialty medicines, supporting pharmacy acquisition strategy in healthcare deals FL. Angelini Pharma acquisitions aim to expand its specialty portfolio through merger acquisition of Catalyst in Coral Gables, Florida. The strategic acquisition is structured as a merger acquisition with Angelini Cielo Inc. as Merger Sub, and stockholders will vote on the Merger Proposal dated May 6, 2026. The healthcare M&A deal remains announced with undisclosed deal value and includes an advisory vote on merger-related executive compensation.